Related references
Note: Only part of the references are listed.Efficacy and Safety of 5-HT4 Receptor Agonist Minesapride for Irritable Bowel Syndrome with Constipation in a Randomized Controlled Trial
Shin Fukudo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes et al.
PHARMACOLOGICAL REVIEWS (2021)
The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
Valerio Baldelli et al.
MICROORGANISMS (2021)
Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials
Eric D. Shah et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management
Monica Gros et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Relative Efficacy of Tegaserod in a Systematic Review and Network Meta-analysis of Licensed Therapies for Irritable Bowel Syndrome With Constipation
Christopher J. Black et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies
Lin Wang et al.
JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS (2020)
Targeting the gut microbiota for the treatment of irritable bowel syndrome
Charles C. Herndon et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)
The Glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome
Rebecca O'Brien et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2020)
Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption
Ian B. Jeffery et al.
GASTROENTEROLOGY (2020)
The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge
Amir Mari et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Neuropeptides in gut-brain axis and their influence on host immunity and stress
Pingli Wei et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Microbiota-neuroimmune cross talk in stress-induced visceral hypersensitivity of the bowel
Isabelle A. M. van Thiel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
Thorough QT/QTc Study Shows That a Novel 5-HT4 Receptor Partial Agonist Minesapride Has No Effect on QT Prolongation
Tatsuto Hamatani et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2020)
Intestinal epithelial barrier and neuromuscular compartment in health and disease
Vanessa D'Antongiovanni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Global burden of irritable bowel syndrome: trends, predictions and risk factors
Christopher J. Black et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Implications of antibiotics use during the COVID-19 pandemic: present and future
Carla Miranda et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Short chain fatty acids in human gut and metabolic health
E. E. Blaak et al.
BENEFICIAL MICROBES (2020)
Potential neuro-immune therapeutic targets in irritable bowel syndrome
Maite Casado-Bedmar et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis
Wenting Zhong et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2019)
Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis
Andreina Baj et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing: A Systematic Review
Ruqiao Duan et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
Mihai Covasa et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens
Charles Burdet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review
Rapat Pittayanon et al.
GASTROENTEROLOGY (2019)
Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health
Kaitlyn Oliphant et al.
MICROBIOME (2019)
Factors affecting the composition of the gut microbiota, and its modulation
Nihal Hasan et al.
PEERJ (2019)
An insight into gut microbiota and its functionalities
Atanu Adak et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome
Dervla O'Malley
EXPERIMENTAL PHYSIOLOGY (2019)
Antibiotic discovery: history, methods and perspectives
Guillaume Andre Durand et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans
Bastiaan W. Haak et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Probiotics importance and their immunomodulatory properties
Bahman Yousefi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats
Jindong Zhang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Proteomic analysis of olfactory bulb suggests CACNA1E as a promoter of CREB signaling in microbiota-induced depression
Cheng Huang et al.
JOURNAL OF PROTEOMICS (2019)
The effect of antibiotics on the composition of the intestinal microbiota - a systematic review
Petra Zimmermann et al.
JOURNAL OF INFECTION (2019)
Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D
Sandra Maria Barbalho et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)
New insights into irritable bowel syndrome: from pathophysiology to treatment
Alexandros Hadjivasilis et al.
ANNALS OF GASTROENTEROLOGY (2019)
Glucagon-Like Peptide-1 Inhibits Prandial Gastrointestinal Motility Through Myenteric Neuronal Mechanisms in Humans
Md. Abdul Halim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity
J. J. Worthington et al.
MUCOSAL IMMUNOLOGY (2018)
Anxiety, Depression, and the Microbiome: A Role for Gut Peptides
Gilliard Lach et al.
NEUROTHERAPEUTICS (2018)
Neurotransmitter modulation by the gut microbiota
Philip Strandwitz
BRAIN RESEARCH (2018)
Intestinal Crosstalk between Microbiota and Serotonin and its Impact on Gut Motility
Xiaolong Ge et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
Antibiotic exposure in early life and childhood overweight and obesity: A systematic review and meta-analysis
Sara H. Rasmussen et al.
DIABETES OBESITY & METABOLISM (2018)
Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome
Nitsan Maharshak et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Eili Y. Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Altered Intestinal Microbiota with Increased Abundance of Prevotella Is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome
Tingting Su et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2018)
Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
Jing Gao et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Bifidobacterium longum and Lactobacillus helveticus Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation
Afifa Ait-Belgnaoui et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Enterochromaffin 5-HT cells - A major target for GLP-1 and gut microbial metabolites
Mari L. Lund et al.
MOLECULAR METABOLISM (2018)
The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS)
Eamonn M. M. Quigley
JOURNAL OF CLINICAL MEDICINE (2018)
Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort
Laura Rindom Krogsgaard et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Microbial tryptophan catabolites in health and disease
Henrik M. Roager et al.
NATURE COMMUNICATIONS (2018)
Antibiotics, Resistome and Resistance Mechanisms: A Bacterial Perspective
Insha Sultan et al.
FRONTIERS IN MICROBIOLOGY (2018)
Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
Xiaojun Zhuang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome
Alexander C. Ford et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
Arnau Vich Vila et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Immunomodulatory Effects of Probiotics on Cytokine Profiles
Md. Abul Kalam Azad et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Visceral pain: gut microbiota, a new hope?
Matteo M. Pusceddu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Short- and long-term effects of oral vancomycin on the human intestinal microbiota
Sandrine Isaac et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Early-life antibiotic treatment enhances the pathogenicity of CD4+ T cells during intestinal inflammation
Sebastian Scheer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition
J. Keller et al.
MOLECULAR PSYCHIATRY (2017)
Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis
Fabiane Klem et al.
GASTROENTEROLOGY (2017)
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Sohn Kim et al.
IMMUNOLOGICAL REVIEWS (2017)
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
Mireia Lopez-Siles et al.
ISME JOURNAL (2017)
Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis
Xiaojun Zhuang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases
John B. Grigg et al.
JOURNAL OF IMMUNOLOGY (2017)
Microbiome-Modulated Metabolites at the Interface of Host Immunity
Eran Blacher et al.
JOURNAL OF IMMUNOLOGY (2017)
Irritable Bowel Syndrome
Alexander C. Ford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice
Giada De Palma et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome
Zheng-Yang Li et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Microbiota Modulate Anxiety-Like Behavior and Endocrine Abnormalities in Hypothalamic-Pituitary-Adrenal Axis
Ran Huo et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Lactic Acid Bacteria and Bifidobacteria with Potential to Design Natural Biofunctional Health-Promoting Dairy Foods
Daniel M. Linares et al.
FRONTIERS IN MICROBIOLOGY (2017)
The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis
Changhyun Lee et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials
Yongping Zheng et al.
PLOS ONE (2017)
Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome
Michiko Kano et al.
SCIENTIFIC REPORTS (2017)
Prospective randomized controlled study on the effects of &ITSaccharomyces boulardii&IT CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers
Toufic A. Kabbani et al.
GUT MICROBES (2017)
Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: Association with digestive symptoms and quality of life
Razieh Choghakhori et al.
CYTOKINE (2017)
A Review on Antibiotic Resistance: Alarm Bells are Ringing
Sojib Bin Zaman et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2017)
Introduction to the human gut microbiota
Elizabeth Thursby et al.
BIOCHEMICAL JOURNAL (2017)
History of antimicrobial drug discovery: Major classes and health impact
Rustam Aminov
BIOCHEMICAL PHARMACOLOGY (2017)
Gut microbiota of mice putatively modifies amino acid metabolism in the host brain
Takahiro Kawase et al.
BRITISH JOURNAL OF NUTRITION (2017)
Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis
Hai-Ning Liu et al.
DIGESTIVE AND LIVER DISEASE (2017)
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases
Lan Lin et al.
BMC IMMUNOLOGY (2017)
The role of mast cells in functional GI disorders
Mira M. Wouters et al.
GUT (2016)
The initial state of the human gut microbiome determines its reshaping by antibiotics
Frederic Raymond et al.
ISME JOURNAL (2016)
Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium-induced colitis in mice
D. Ahl et al.
ACTA PHYSIOLOGICA (2016)
Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating
Tamar Ringel-Kulka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Nutrition meets the microbiome: micronutrients and the microbiota
Hans K. Biesalski
NUTRITION AND THE MICROBIOME (2016)
Antibiotics, obesity and the link to microbes - what are we doing to our children?
Olli Turta et al.
BMC MEDICINE (2016)
Antibiotics as deep modulators of gut microbiota: between good and evil
Gianluca Ianiro et al.
GUT (2016)
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism
P. Zheng et al.
MOLECULAR PSYCHIATRY (2016)
Interplay between bile acid metabolism and microbiota in irritable bowel syndrome
M. Dior et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2016)
The Human Intestinal Microbiome in Health and Disease
Susan V. Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
Simone Becattini et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals
Amar Sarkar et al.
TRENDS IN NEUROSCIENCES (2016)
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments
Mohammad H. Farzaei et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2016)
How gut microbes talk to organs: The role of endocrine and nervous routes
Patrice D. Cani et al.
MOLECULAR METABOLISM (2016)
Irritable bowel syndrome
Paul Enck et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties
Alain P. Gobert et al.
SCIENTIFIC REPORTS (2016)
Gut microbiota, metabolites and host immunity
Michelle G. Rooks et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Irritable bowel syndrome, the microbiota and the gut-brain axis
Hans Raskov et al.
GUT MICROBES (2016)
The microbiome: A key regulator of stress and neuroinflammation
Kieran Rea et al.
NEUROBIOLOGY OF STRESS (2016)
Pathophysiology of irritable bowel syndrome
Gerald J. Holtmann et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects
I. Rangel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods
Mamun-Ur Rashid et al.
CLINICAL INFECTIOUS DISEASES (2015)
Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis
Ratnakar Shukla et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Molecular and cellular mechanisms of tight junction dysfunction in the irritable bowel syndrome
Peng Cheng et al.
MOLECULAR MEDICINE REPORTS (2015)
Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders
H. Paula et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2015)
GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation
Michelangelo Auteri et al.
PHARMACOLOGICAL RESEARCH (2015)
Microbiota and host determinants of behavioural phenotype in maternally separated mice
G. De Palma et al.
NATURE COMMUNICATIONS (2015)
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome
Marta Pozuelo et al.
SCIENTIFIC REPORTS (2015)
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
Lorena Baietto et al.
CURRENT DRUG METABOLISM (2014)
Short-Term Effect of Antibiotics on Human Gut Microbiota
Suchita Panda et al.
PLOS ONE (2014)
The SCFA receptor GPR43 and energy metabolism
Ikuo Kimura et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers A randomized clinical trial
Kumar Pallav et al.
GUT MICROBES (2014)
Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent
Laura Wrzosek et al.
BMC BIOLOGY (2013)
Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα
Caroline Swan et al.
GUT (2013)
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Koji Atarashi et al.
NATURE (2013)
Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets
Gary M. Mawe et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis
Patrick M. Smith et al.
SCIENCE (2013)
Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome
Michael Camilleri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
G-Protein-Coupled Receptors in Intestinal Chemosensation
Frank Reimann et al.
CELL METABOLISM (2012)
Complex Carbohydrate Utilization by the Healthy Human Microbiome
Brandi L. Cantarel et al.
PLOS ONE (2012)
Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats
Afifa Ait-Belgnaoui et al.
PSYCHONEUROENDOCRINOLOGY (2012)
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Xochitl C. Morgan et al.
GENOME BIOLOGY (2012)
Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation
Michael T. Bailey et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Enterobacteriaceae Act in Concert with the Gut Microbiota to Induce Spontaneous and Maternally Transmitted Colitis
Wendy S. Garrett et al.
CELL HOST & MICROBE (2010)
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans
Caries Ubeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
A human gut microbial gene catalogue established by metagenomic sequencing
Junjie Qin et al.
NATURE (2010)
Increased Immunoendocrine Cells in Intestinal Mucosa of Postinfectious Irritable Bowel Syndrome Patients 3 Years after Acute Shigella Infection - An Observation in a Small Case Control Study
Hee Sun Kim et al.
YONSEI MEDICAL JOURNAL (2010)
Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces
Satoru Fukiya et al.
FEMS MICROBIOLOGY LETTERS (2009)
Principles and clinical implications of the brain-gut-enteric microbiota axis
Sang H. Rhee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Effects of 5-hydroxytryptamine (serotonin) type 3 antagoniosts on symptom relief and constipation in nonconstipated irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials
Viola Andresen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease
Sofia Tedelind et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation
B. W. Evans et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Metagenomic analysis of the human distal gut microbiome
Steven R. Gill et al.
SCIENCE (2006)
A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence
AI Sharara et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Diversity of the human intestinal microbial flora
PB Eckburg et al.
SCIENCE (2005)
Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice
N Sudo et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Share Paper
